StockData

Yarrow Bioscience, Inc. (YARW) stock

YARWNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 11/30102% above fair value
$14.21+0.28 (+2.01%)

Close on Nov 17, 2026Market cap $37.94MP/E –Yield –

Yarrow Bioscience operating margin

Operating margin is operating income as a percentage of revenue.

Yarrow Bioscience's operating margin for the twelve months ending Jun 30, 2025 was -8949.6%. For fiscal 2025 it was -5219.1%, against -8710.0% the year before. The highest annual figure on record is -645.9% in fiscal 2017.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-5219.1%+3490.9
FY2024Dec 31, 2024-8710.0%−1809.5
FY2023Dec 31, 2023-6900.5%+289.3
FY2022Dec 31, 2022-7189.7%−3010.2
FY2021Dec 31, 2021-4179.5%−2976.5
FY2020Dec 31, 2020-1203.0%+20438.8
FY2019Dec 31, 2019-21641.8%−19558.5
FY2018Dec 31, 2018-2083.2%−1437.4
FY2017Dec 31, 2017-645.9%+1480.6
FY2016Dec 31, 2016-2126.4%–

Quarterly operating margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 2026-3197.9%+12004.4
Q1 FY2026Mar 31, 2026-4437.2%+6381.8
Q2 FY2025Jun 30, 2025-10930.4%−5679.9
Q1 FY2025Mar 31, 2025-4553.0%+2977.6
Q4 FY2024Dec 31, 2024-15202.4%−6212.9
Q3 FY2024Sep 30, 2024-10819.0%−5350.6
Q2 FY2024Jun 30, 2024-5250.5%+2392.5
Q1 FY2024Mar 31, 2024-7530.6%−1596.3
Q4 FY2023Dec 31, 2023-8989.5%+124077.2
Q3 FY2023Sep 30, 2023-5468.4%+120.2
Q2 FY2023Jun 30, 2023-7643.0%−1066.0
Q1 FY2023Mar 31, 2023-5934.3%−1051.8
Q4 FY2022Dec 31, 2022-133066.7%−129826.4
Q3 FY2022Sep 30, 2022-5588.6%+2506.9
Q2 FY2022Jun 30, 2022-6577.0%−3342.4
Q1 FY2022Mar 31, 2022-4882.6%−640.4
Q4 FY2021Dec 31, 2021-3240.3%−2727.3
Q3 FY2021Sep 30, 2021-8095.5%−7376.9
Q2 FY2021Jun 30, 2021-3234.6%−1804.2
Q1 FY2021Mar 31, 2021-4242.2%−1962.8
Q4 FY2020Dec 31, 2020-513.0%+27213.6
Q3 FY2020Sep 30, 2020-718.6%+4438.5
Q2 FY2020Jun 30, 2020-1430.3%−1339.9
Q1 FY2020Mar 31, 2020-2279.4%+380.6
Q4 FY2019Dec 31, 2019-27726.7%−27385.2
Q1 FY2019Mar 31, 2019-5157.1%−4240.2
Q2 FY2018Jun 30, 2018-90.4%+1296.0
Q1 FY2018Mar 31, 2018-2660.0%−1422.8
Q4 FY2017Dec 31, 2017-341.5%–
Q3 FY2017Sep 30, 2017-916.9%–
Q2 FY2017Jun 30, 2017-1386.4%–
Q1 FY2017Mar 31, 2017-1237.2%–

More Yarrow Bioscience figures

See a number that looks wrong?